HIV Proteins and Their Cellular Binding Partners (R21/R33)

The summary for the HIV Proteins and Their Cellular Binding Partners (R21/R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
HIV Proteins and Their Cellular Binding Partners (R21/R33): -The aim of this initiative is to promote collaborations between biochemists and structural biologists to define the interactions of HIV proteins with their host-cell partners towards determining the three dimensional structure of these complexes. The goal is to gain an in-depth understanding of HIV protein-containing complexes throughout the virus life cycle. A better understanding of these interactions will lead to new avenues for therapeutic interventions in HIV disease. -Mechanism of Support. Awards will support milestone-driven exploratory/feasibility proof of concept studies (2 year R21 phase), with possible rapid transition to expanded development (3 year R33 phase). -Funds Available. Funding will be based on scientific and technical merit, program priorities, and availability of funds. The R21 award will be limited to $275,000 direct costs over the two year award period, and the R33 award will be limited to $250,000 in direct costs per annum. NIH anticipates that a maximum of fifty percent (50%) of the funded R21 phase awards will progress to the R33 award. -Eligible organizations. For-profit and non-profit organizations, foreign and domestic public or private institutions such as universities, colleges, hospitals, laboratories, and faith-based or community-based organizations, Indian/Native American Tribal Governments (Federally Recognized); Indian/Native American Tribal Governments (Other than Federally Recognized); and Indian/Native American Tribally Designated Organizations. units of state and local government, and eligible agencies of the federal government, are eligible to apply for funding under this announcement. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply. -Eligible Project Directors/Principal Investigators (PDs/PIs): Any individuals from the applicant institutions who have the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Application and Submission Information, and Specific Instructions for Preparing Combined R21/R33 Application. The R21/R33 Phased Innovation Award application must be submitted as a single application, and applicants should note specific instructions for each phase. -Applicants may submit more than one application, provided each application is scientifically distinct. -All investigator-initiated exploratory/developmental grant applications described in this announcement will be assigned to Institutes and Centers (ICs) according to standard Public Health Service (PHS) referral guidelines and specific program interests.
Federal Grant Title: HIV Proteins and Their Cellular Binding Partners (R21/R33)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-388
Type of Funding: Grant
CFDA Numbers: 93.85593.856
CFDA Descriptions: Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: May 05, 2006
Creation Date: May 05, 2006
Archive Date: Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts County governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as the Project Director/Principal Investigator (PD/PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognit...
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognit...
Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Option...
Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Ear...
Limited Competition: Competitive Revision Awards for the Clinical and Translational Scienc...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com